{"id":35718,"date":"2025-01-25T22:08:01","date_gmt":"2025-01-25T14:08:01","guid":{"rendered":"https:\/\/hteknologi.com\/blog\/?p=35718"},"modified":"2025-01-25T22:08:01","modified_gmt":"2025-01-25T14:08:01","slug":"cov-biotechnology-leyden-labs-asia","status":"publish","type":"post","link":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/","title":{"rendered":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan"},"content":{"rendered":"

Singapura, 22 Januari 2025<\/strong> \u2013 CoV Biotechnology (\u201cCoVBio\u201d), sebuah syarikat bioteknologi Singapura, telah diambil alih oleh Leyden Laboratories B.V.<\/strong> (\u201cLeyden Labs\u201d), sebuah syarikat bioteknologi global berpangkalan di Belanda. CoV Biotechnology kini beroperasi sebagai Leyden Labs Asia<\/strong>, anak syarikat milik penuh Leyden Laboratories B.V., dan akan membangun berdasarkan asas kukuh Leyden Labs untuk mengembangkan perniagaan di rantau Asia Pasifik.<\/p>\n

Ditubuhkan pada tahun 2022, CoVBio berfokus untuk membangun dan mengkomersialkan teknologi yang dicipta oleh Profesor Wang Linfa<\/strong> dari Duke-NUS Medical School<\/strong>, yang memainkan peranan penting dalam respons Singapura terhadap pandemik SARS-CoV-2. Portfolio CoVBio merangkumi aset vaksin dan antibodi monoklonal yang berkesan terhadap spektrum luas beta-koronavirus<\/strong>, termasuk SARS-CoV-2, SARS-CoV-1, dan virus zoonotik lain yang berpotensi menular dari haiwan kepada manusia.<\/p>\n

Leyden Labs: Perintis Penyakit Berjangkit Pernafasan<\/strong><\/h3>\n

Leyden Labs ialah syarikat penyakit berjangkit yang berfokus untuk membebaskan dunia daripada virus pernafasan. Berdasarkan Mucosal Protection Platform<\/strong> miliknya, Leyden Labs sedang membangunkan portfolio antibodi intranasal. Semburan hidung bukan vaksin ini bertujuan melindungi daripada influenza, koronavirus, dan virus pernafasan lain. Leyden Labs kini menjalankan ujian klinikal untuk menunjukkan potensi pengurangan jangkitan pernafasan dan perlindungan daripada penyakit teruk. Dengan pelancaran Leyden Labs Asia<\/strong>, syarikat ini memperkukuh platformnya dan meningkatkan aktiviti kesiapsiagaan pandemik.<\/p>\n

Dr. Rosemary Tan<\/strong>, Ketua Pegawai Eksekutif CoVBio, berkata:<\/p>\n

\n

\u201cDengan kebimbangan yang semakin meningkat terhadap influenza burung dan penyakit pernafasan lain di seluruh dunia, kita tidak boleh leka. Kita mesti meneruskan usaha kesiapsiagaan pandemik. Kami berbesar hati untuk bekerjasama dengan pasukan luar biasa di Leyden Labs, memanfaatkan kepakaran, infrastruktur, dan rangkaian kami di rantau ini untuk terus mencapai misi bersama.\u201d<\/p><\/blockquote>\n<\/blockquote>\n

Pendekatan Proaktif dan Kolaborasi untuk Kesiapsiagaan Pandemik<\/strong><\/h3>\n

Profesor Wang<\/strong> dari Program Penyakit Berjangkit Baru Muncul Duke-NUS berkata:<\/p>\n

\n

\u201cUntuk memastikan intervensi awal terhadap ancaman pandemik yang berpotensi, kita memerlukan pendekatan yang lebih proaktif dan berwaspada, dengan fokus kepada penyelesaian broad-spectrum<\/strong> yang inovatif dan bebas patogen. Kerjasama erat antara penyelidik dan rakan industri juga sangat penting untuk memajukan penemuan menjadi penyelesaian klinikal yang boleh digunakan, memperkukuh keupayaan global dalam kesiapsiagaan pandemik.\u201d<\/p><\/blockquote>\n<\/blockquote>\n

Koenraad Wiedhaup<\/strong>, pengasas bersama dan Ketua Pegawai Eksekutif Leyden Labs, menambah:<\/p>\n

\n

\u201cSingapura, dengan saintis penyakit berjangkit terkemuka seperti Profesor Wang, memberi fokus besar terhadap inisiatif wabak virus. Singapura adalah pangkalan yang sangat baik untuk aktiviti kesiapsiagaan pandemik kami di Asia. Kami melihat sinergi kuat dalam penyelidikan dan pembangunan, dan sangat teruja untuk bekerjasama mencapai perlindungan daripada penyakit pernafasan di seluruh dunia. Dengan perkembangan terbaru flu burung (H5N1), ia menjadi semakin penting dan mendesak untuk melaksanakan misi kami melindungi manusia daripada virus baharu dan sedia ada.\u201d<\/p><\/blockquote>\n<\/blockquote>\n

Peluang Baru untuk Impak Global<\/strong><\/h3>\n

Khoo Shih<\/strong>, Ketua Pegawai Eksekutif ClavystBio, salah seorang pelabur Leyden Labs, berkata:<\/p>\n

\n

\u201cPemerolehan CoVBio oleh Leyden Labs mencipta peluang menarik untuk membangunkan syarikat dengan impak global. Ini selari dengan misi ClavystBio untuk mempercepatkan komersialisasi sains hayat dari ekosistem sains hayat Singapura yang dinamik. Kami tidak sabar untuk bekerjasama dengan pasukan pengurusan berpengalaman seperti Koenraad dan Rosemary, serta inovator berwawasan seperti Prof Wang, untuk memajukan misi Leyden Labs melindungi dunia daripada virus pernafasan baharu dan sedia ada.\u201d<\/p><\/blockquote>\n<\/blockquote>\n

Imej pengatas oleh fernando zhiminaicela<\/a> dari Pixabay<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Singapura, 22 Januari 2025 \u2013 CoV Biotechnology (\u201cCoVBio\u201d), sebuah syarikat bioteknologi Singapura, telah diambil alih oleh Leyden Laboratories B.V. (\u201cLeyden Labs\u201d), sebuah syarikat bioteknologi global berpangkalan di Belanda. CoV Biotechnology kini beroperasi sebagai Leyden Labs Asia, anak syarikat milik penuh Leyden Laboratories B.V., dan akan membangun berdasarkan asas kukuh Leyden Labs untuk mengembangkan perniagaan di […]<\/p>\n","protected":false},"author":3,"featured_media":35719,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"tdm_status":"","tdm_grid_status":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[10],"tags":[1079,9860],"class_list":["post-35718","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kesihatan","tag-teknologi","tag-teknologi-bio"],"yoast_head":"\nCoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan<\/title>\n<meta name=\"description\" content=\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan\" \/>\n<meta name=\"twitter:description\" content=\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1\" \/>\n<meta name=\"twitter:creator\" content=\"@hteknologimy\" \/>\n<meta name=\"twitter:site\" content=\"@hteknologimy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Meja Berita\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/\"},\"author\":{\"name\":\"Meja Berita\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#\\\/schema\\\/person\\\/670d7ca1beed8e88520315c869bc34a1\"},\"headline\":\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan\",\"datePublished\":\"2025-01-25T14:08:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/\"},\"wordCount\":509,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1\",\"keywords\":[\"teknologi\",\"Teknologi Bio\"],\"articleSection\":[\"Kesihatan\"],\"inLanguage\":\"ms-MY\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/\",\"url\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/\",\"name\":\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1\",\"datePublished\":\"2025-01-25T14:08:01+00:00\",\"description\":\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#breadcrumb\"},\"inLanguage\":\"ms-MY\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1\",\"width\":640,\"height\":427,\"caption\":\"Imej daripada Fernando Zhiminaicela, Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/cov-biotechnology-leyden-labs-asia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Utama\",\"item\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/\",\"name\":\"Harian Teknologi\",\"description\":\"Berita Teknologi di Malaysia dan Dunia Terkini\",\"publisher\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ms-MY\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#organization\",\"name\":\"Harian Teknologi\",\"url\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Harian-Teknologi-Favicon-1.png\",\"contentUrl\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Harian-Teknologi-Favicon-1.png\",\"width\":500,\"height\":500,\"caption\":\"Harian Teknologi\"},\"image\":{\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/HarianTeknologi\\\/\",\"https:\\\/\\\/x.com\\\/hteknologimy\",\"https:\\\/\\\/www.instagram.com\\\/harian_teknologi\\\/\",\"https:\\\/\\\/youtube.com\\\/channel\\\/UCKIL4apJm-3TUxKKGle9S5w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/#\\\/schema\\\/person\\\/670d7ca1beed8e88520315c869bc34a1\",\"name\":\"Meja Berita\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g\",\"caption\":\"Meja Berita\"},\"description\":\"Terus dari meja pengarang berita Harian Teknologi. Akhbar teknologi nombor 3 di Malaysia!\",\"url\":\"https:\\\/\\\/hteknologi.com\\\/blog\\\/author\\\/abdul\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan","description":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/","twitter_card":"summary_large_image","twitter_title":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan","twitter_description":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui","twitter_image":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","twitter_creator":"@hteknologimy","twitter_site":"@hteknologimy","twitter_misc":{"Written by":"Meja Berita","Est. reading time":"2 minit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#article","isPartOf":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/"},"author":{"name":"Meja Berita","@id":"https:\/\/hteknologi.com\/blog\/#\/schema\/person\/670d7ca1beed8e88520315c869bc34a1"},"headline":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan","datePublished":"2025-01-25T14:08:01+00:00","mainEntityOfPage":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/"},"wordCount":509,"commentCount":0,"publisher":{"@id":"https:\/\/hteknologi.com\/blog\/#organization"},"image":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","keywords":["teknologi","Teknologi Bio"],"articleSection":["Kesihatan"],"inLanguage":"ms-MY","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/","url":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/","name":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan","isPartOf":{"@id":"https:\/\/hteknologi.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#primaryimage"},"image":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","datePublished":"2025-01-25T14:08:01+00:00","description":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan. Melalui","breadcrumb":{"@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#breadcrumb"},"inLanguage":"ms-MY","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/"]}]},{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#primaryimage","url":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","width":640,"height":427,"caption":"Imej daripada Fernando Zhiminaicela, Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/hteknologi.com\/blog\/cov-biotechnology-leyden-labs-asia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Utama","item":"https:\/\/hteknologi.com\/blog\/"},{"@type":"ListItem","position":2,"name":"CoV Biotechnology Melangkah ke Hadapan Sebagai Leyden Labs Asia, Meneruskan Misi Memerangi Penyakit Berjangkit Pernafasan"}]},{"@type":"WebSite","@id":"https:\/\/hteknologi.com\/blog\/#website","url":"https:\/\/hteknologi.com\/blog\/","name":"Harian Teknologi","description":"Berita Teknologi di Malaysia dan Dunia Terkini","publisher":{"@id":"https:\/\/hteknologi.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hteknologi.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ms-MY"},{"@type":"Organization","@id":"https:\/\/hteknologi.com\/blog\/#organization","name":"Harian Teknologi","url":"https:\/\/hteknologi.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/hteknologi.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/hteknologi.com\/blog\/wp-content\/uploads\/2024\/05\/Harian-Teknologi-Favicon-1.png","contentUrl":"https:\/\/hteknologi.com\/blog\/wp-content\/uploads\/2024\/05\/Harian-Teknologi-Favicon-1.png","width":500,"height":500,"caption":"Harian Teknologi"},"image":{"@id":"https:\/\/hteknologi.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HarianTeknologi\/","https:\/\/x.com\/hteknologimy","https:\/\/www.instagram.com\/harian_teknologi\/","https:\/\/youtube.com\/channel\/UCKIL4apJm-3TUxKKGle9S5w"]},{"@type":"Person","@id":"https:\/\/hteknologi.com\/blog\/#\/schema\/person\/670d7ca1beed8e88520315c869bc34a1","name":"Meja Berita","image":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/secure.gravatar.com\/avatar\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/55c403fc46916d8b90c90c1aeabbcedd943da0c08e80ce0eb11e406717467b71?s=96&d=wavatar&r=g","caption":"Meja Berita"},"description":"Terus dari meja pengarang berita Harian Teknologi. Akhbar teknologi nombor 3 di Malaysia!","url":"https:\/\/hteknologi.com\/blog\/author\/abdul\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/hteknologi.com\/blog\/wp-content\/uploads\/2025\/01\/Virus-Merbahaya.jpg?fit=640%2C427&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/p5oWzh-9i6","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/posts\/35718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/comments?post=35718"}],"version-history":[{"count":1,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/posts\/35718\/revisions"}],"predecessor-version":[{"id":35720,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/posts\/35718\/revisions\/35720"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/media\/35719"}],"wp:attachment":[{"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/media?parent=35718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/categories?post=35718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hteknologi.com\/blog\/wp-json\/wp\/v2\/tags?post=35718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}